In this research, we observed that reducing miR-155 levels could mitigate the inflammatory response in LPS-treated FHC cells and NEC rat intestinal tissues, evidenced by a corresponding decrease in p-IκBα, p65, IL-6, and TNF-α. This evidence concerns the gene TNF and necrotizing enterocolitis.